United States-based medical devices and health care company Abbott (NYSE: ABT) announced on Friday that its board of directors declared a quarterly common dividend of USD0.59 per share.
This represents the 405th consecutive quarterly dividend since 1924. Payment is scheduled for 15 May 2025, to shareholders of record as of 15 April 2025.
Abbott has raised its dividend for 53 consecutive years. Inclusion in the S&P 500 Dividend Aristocrats Index reflects its commitment to annual dividend increases for over 25 years.
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo